Investor Relations
Jan 07, 2019
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories MORE >>
Dec 27, 2018
OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action MORE >>
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>

SEC Filing Details

Document Details

Filing Date
Feb 24, 2009
Document Date
Feb 13, 2009
Form Description
A preliminary proxy statement containing all other information
Filing Group
Proxy Filings
OPKO Health, Inc.